This study demonstrated that the small molecule kenpaullone increases SHMT2 expression, which in turn promotes ADAM10 translation, potentially leading to amelioration of AD-related pathology in a mouse model (Song et al., 2024). The gene discussed is SHMT2; the disease is Alzheimer disease.